期刊文献+

禽源大肠埃希菌质粒介导的喹诺酮类药物耐药基因的检测 被引量:8

Detection of Plasmid-mediated Quinolone Resistance among Escherchia coli from Avian in China
下载PDF
导出
摘要 从我国部分地区病、死家禽中分离到大肠埃希菌403株。按照CLSI(clinical and laboratory standards institute)推荐的K-B药敏纸片法对其中的344株分离株进行药敏纸片试验;根据GenBank上发表的序列,设计并合成了五对引物,对所有分离细菌进行质粒介导的喹诺酮类药物耐药基因的扩增:qnrA、qnrB、qnrS、aac(6′)-ib-cr和qepA。1993年-1996年禽源大肠埃希菌分离株仅对萘啶酸的耐药率超过60%;2001年-2008年禽源大肠埃希菌分离株对1-3代7种喹诺酮类药物的耐药率均超过58%。在403株禽源大肠埃希菌中共检出3(0.7%)株qnrB阳性菌株,2(0.5%)株qnrS阳性菌株,5(1.2%)株aac(6′)-ib-cr阳性菌株以及5(1.2%)株qepA阳性菌株,未检测到qnrA阳性菌株。结果显示,近20年来,我国禽源大肠埃希菌对喹诺酮类药物的耐药性不断上升,同时,质粒介导的喹诺酮类药物耐药基因在禽源大肠埃希菌中呈不断上升的流行趋势。 A total of 403 E.coli field isolates were derived from clinically affected chickens in 18 provinces of China between 1993 and 2009.Of which 344 E.coli isolates from 1990s were carried out to 8 quinolone antimicrobial sensitivity test by using the Kirby-Bauer method recommended by CLSI(clinical and laboratory standards institute).All of the isolates were detected for the presence of qnrA,qnrB,qnrS,aac(6′)-ib-cr and qepA by PCR and sequencing.E.coli isolates from 1993-1996 had a resistance more than 60% only to Nalicixic acid(61.6%),whereas isolates from 2001-2008 had a resistance more than 58% to 7 antibiotics.Among the 403 E.coli isolates from China,qnrB,qnrS,aac(6′)-ib-cr and qepA were detected in 3(0.7%),2(0.5%),5(1.2%),and 5(1.2%) isolates,respectively,no qnrA positive isolate was detected in this study.The results showed that the resistance of E.coli to quinolone agents had been increasing in the past twenty years and there was a rising prevalence of E.coli isolates harboring plasmid-mediated quinolone resistance genes in China.
出处 《动物医学进展》 CSCD 北大核心 2010年第S1期74-78,共5页 Progress In Veterinary Medicine
基金 江苏省自然科学基金(BK2008011) 江苏省高校自然科学研究项目(09KJB230002) 江苏省重点实验室开放课题(K07016)
关键词 大肠埃希菌 喹诺酮耐药性 质粒介导 avian Escherchia coli quinolone resistance plasmid mediation
  • 相关文献

参考文献13

  • 1王晓泉,焦新安,刘晓文,陈祥,宦海霞,刘秀梵.江苏部分地区食源性和人源沙门氏菌的多重耐药性研究[J].微生物学报,2007,47(2):221-227. 被引量:88
  • 2刘健华,陈杖榴.喹诺酮类抗菌药耐药新机制[J].中国兽医杂志,2007,43(1):54-57. 被引量:11
  • 3Clinical and Laboratory Standards Institute(CLSI).Performancestandards for anti microbial susceptibility testing;Nineteenthinformational supplement. CLSI document M100-S19 . 2009
  • 4Guerra B,,Junker E,Schroeter A,et al.Phenotypic and geno-typic characterization of anti microbial resistance in GermanEscherichia coliisolates fromcattle,swine and poultry. JAnti microb Chemoth . 2003
  • 5Martinez-Martinez L,Pascual A,Jacoby GA.Quinolone resistance from a transferable plasmid. The Lancet . 1998
  • 6Hata M,Suzuki M,Matsumoto M,et al.Cloning of a novel gene for quinolone resistance from a transferable plasmid in Shigella flexneri 2b. Antimicrobial Agents and Chemotherapy . 2005
  • 7Jacoby GA,,Walsh KE,Mills DM,et al.qnrB,another plasmidmediated gene for quinolone resistance. Antimicrobial Agents and Chemotherapy . 2006
  • 8Park CH,Robicsek A,Jacoby GA,et al.Prevalence in the United States of aac(6)-Ib-cr encoding a ciprofloxacin-modif- ying enzyme. Antimicrobial Agents and Chemotherapy . 2006
  • 9Yamane K,Wachino JI,Suzuki S,et al.New plasmid-mediated fluoroquinolone efflux pump,qepA,found in anEscherichia coli clinical isolate. Antimicrobial Agents and Chemotherapy . 2007
  • 10Cattotir V,Poirel L,Rotimi V,et al.Multiplex PCR for detectionof plasmid-mediated quinolone resistance qnr genes in ESBL-pro-ducing enterobacterial isolates. Journal of Antimicrobial Chemotherapy . 2007

二级参考文献32

  • 1AusubelF BrentR KingstonRE etal 颜子颖 王海林 译.精编分子生物学实验指南[M].北京:科学出版社,1998..
  • 2Cheung T K,Chu Y W,Chu M Y,et al.Plasmid-mediated resistance to ciprofloxacin and cefotaxime in clinical isolates of Salmonella enterica serotype Enteritidis in Hong Kong[J].J Antimicrob Chemother,2005,56(3):586-589.
  • 3Saga T,Kaku M,Onodera Y,et al.Vibrio parahaemolyticus chromosomal qnr homologue VPA0095:demonstration by transformation with a mutated gene of its potential to reduce quinolone susceptibility in Escherichia coli[J].Antimicrob Agents Chemother,2005,49(5):2144-2145.[16] Montero C,Mateu G,Rodriguez R,et al.Intrinsic resistanceof Mycobacterium smegmatis to fluoroquinolones may be influenced by new pentapeptide protein mfpA[J].Antimicrob Agents Chemother,2001,45(12):3387-3392.
  • 4Montero C, Mateu G, Rodriguez R, et al. Intrinsic resistance of Myeobaeterium smegmatis to fluoroquinolones may be influenced by new pentapeptide protein mfpA[J]. Antimierob Agents Chemother, 2001, 45(12):3387-3392.
  • 5Hegde S S,Vetting M W,Roderick SL,et al.A fluoroquinolone resistance protein from Mycobacterium tuberculosis that mimics DNA[J].Science,2005,308(5727):1480-1483.
  • 6Robicsek A,Strahilevita J,Jacoby G A,et al.Fluoroquinolone modifying enzyme:a new adaptation of a common aminoglycoside acetyltransferase[J].Nat Med,2006,12:83-88.
  • 7Martínez-Martínez L,Pascual A,Jacoby G A.Quinolone resistance from a transferable plasmid[J].Lancet,1998,351(9105):797-799.
  • 8Tran J H,Jacoby G A.Mechanism of plasmid-mediated quinolone resistance[J].Proc Natl Acad Sci USA,2002,99(8):5638-5642.
  • 9Tran J H,Jacoby G A,Hooper D C.Interaction of the plasmid-encoded quinolone resistance protein qnr with Escherichia coli DNA gyrase[J].Antimicrob Agents Chemother,2005,49(1):118-125.
  • 10Tran J H,Jacoby G A,Hooper D C.Interaction of the plasmid-encoded quinolone resistance protein qnrA with Escherichia coli topoisomerase IV[J].Antimicrob Agents Chemother,2005,49(7):3050-3052.

共引文献96

同被引文献79

引证文献8

二级引证文献74

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部